Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake. (Q39940184)
Jump to navigation
Jump to search
scientific article published on September 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake. |
scientific article published on September 2008 |
Statements
Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake (English)
Yonglei Shang
Yifan Mao
Jennifer Batson
Suzie J Scales
Gail Phillips
Klara Totpal
Simon Williams
Jihong Yang
Zhijun Tang
Christine Tan
Wei-Ching Liang
Siao Ping Tsai
Alexander Vanderbilt
Kenji Kozuka
Klaus Hoeflich
Janet Tien
Sarajane Ross
Congfen Li
Sang Hoon Lee
An Song
Yan Wu
Jean-Philippe Stephan
Avi Ashkenazi
1 September 2008